BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12104051)

  • 21. Characterization of the 3' untranslated region of mouse DNA topoisomerase IIalpha mRNA.
    Kobayashi M; Adachi N; Koyama H
    Gene; 1998 Jul; 215(2):329-37. PubMed ID: 9714832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of topoisomerase IIalpha in CEM cells selected for merbarone resistance is associated with reduced expression of Sp3.
    Mo YY; Wang Q; Beck WT
    Cancer Res; 1997 Nov; 57(22):5004-8. PubMed ID: 9371492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
    Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
    Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.
    Brandt TL; Fraser DJ; Leal S; Halandras PM; Kroll AR; Kroll DJ
    J Biol Chem; 1997 Mar; 272(10):6278-84. PubMed ID: 9045645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
    Coustry F; Hu Q; de Crombrugghe B; Maity SN
    J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
    Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
    Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
    Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
    Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
    Isaacs RJ; Harris AL; Hickson ID
    J Biol Chem; 1996 Jul; 271(28):16741-7. PubMed ID: 8663303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two differentially spliced forms of topoisomerase IIalpha and beta mRNAs are conserved between birds and humans.
    Petruti-Mot AS; Earnshaw WC
    Gene; 2000 Nov; 258(1-2):183-92. PubMed ID: 11111056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis by depletion of DNA topoisomerase IIalpha in mammalian cells.
    Akimitsu N; Kamura K; Toné S; Sakaguchi A; Kikuchi A; Hamamoto H; Sekimizu K
    Biochem Biophys Res Commun; 2003 Jul; 307(2):301-7. PubMed ID: 12859955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226.
    Wang H; Jiang Zg; Wong YW; Dalton WS; Futscher BW; Chan VT
    Biochem Biophys Res Commun; 1997 Aug; 237(2):217-24. PubMed ID: 9268689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B; Stein JL; van Wijnen AJ; Stein GS
    Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA topoisomerase IIα controls replication origin cluster licensing and firing time in Xenopus egg extracts.
    Gaggioli V; Le Viet B; Germe T; Hyrien O
    Nucleic Acids Res; 2013 Aug; 41(15):7313-31. PubMed ID: 23757188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
    Yun J; Tomida A; Andoh T; Tsuruo T
    J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock.
    Furukawa M; Uchiumi T; Nomoto M; Takano H; Morimoto RI; Naito S; Kuwano M; Kohno K
    J Biol Chem; 1998 Apr; 273(17):10550-5. PubMed ID: 9553115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
    Singh R; Winn LM
    Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homologous and heterologous protein-protein interactions of human DNA topoisomerase IIalpha.
    Kroll DJ
    Arch Biochem Biophys; 1997 Sep; 345(2):175-84. PubMed ID: 9308887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2.
    Kim SJ; Wagner S; Liu F; O'Reilly MA; Robbins PD; Green MR
    Nature; 1992 Jul; 358(6384):331-4. PubMed ID: 1641004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.